Project Grant HT9425261E261
Award Date 7/1/26
Completion Date 6/30/28
Dollars Obligated $560K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37232, USA
Similar Awards
- Federal Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $2.39 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2029. The award funds biomedical research investigating the molecular basis of post-injury syndrome and mineralization disorders, with particular focus on decoding inflammatory mechanisms underlying these conditions. This research...
- Federal Project Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $700,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2025, with a completion date of August 14, 2027. The award supports research investigating the DPEP1-neutrophil axis in microsatellite stable colorectal cancer, contributing to the DHA's broader mission of transforming healthcare for service members and the...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $1,847,457 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2030. The grant supports "Building on the Foundation of the Academy of Kidney Cancer Investigators," a research initiative aimed at advancing biomedical research to transform healthcare for service members and the American public...
- Federal Project Grant Award Summary Vanderbilt University Medical Center received a $1,267,303 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct a three-year research initiative titled "Defining Chronic Immune-Related Adverse Events in Melanoma Survivors." The award, effective August 1, 2025, through July 31, 2028, supports hypothesis-driven biomedical research focused on understanding and...
- Federal Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $2.19 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 1, 2025, through April 30, 2029. This four-year research initiative addresses toxicant-mediated pulmonary hypertension in Southwest Asia veterans, supporting advanced biomedical research designed to transform healthcare for military service members and...
- Federal Project Grant Award Summary Vanderbilt University's Sponsored Programs Administration received a $158,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded June 1, 2025, with completion scheduled for May 31, 2027. The research project, titled "Metabotropic Glutamate Receptor 7 and Learning in NF1," focuses on advancing biomedical understanding of neurological function relevant to military medical...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $3.64 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded September 1, 2025, with a completion date of August 31, 2029. The project, titled "Empowered Relief for Spine Surgery: Improving Outcomes with Innovative Rehabilitation Strategies," focuses on developing and implementing innovative rehabilitation approaches designed to...
- This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...
- Federal Project Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $2.26 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on toxicant-mediated pulmonary hypertension in Southwest Asia veterans. The four-year award, effective May 1, 2025 through April 30, 2029, supports biomedical research addressing health challenges relevant to military service members and veterans...